Amanote Research
Register
Sign In
Cardiovascular Immune‐related Adverse Events: Evaluation, Diagnosis and Management
Asia-Pacific Journal of Clinical Oncology
- United Kingdom
doi 10.1111/ajco.13326
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Date
March 4, 2020
Authors
Yingxian Liu
Wei Wu
Publisher
Wiley
Related search
Management of Immune Checkpoint Inhibitor‐related Dermatologic Adverse Events
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
EL25Management of Immune-Related Adverse Events
Annals of Oncology
Medicine
Oncology
Hematology
Immune Dysregulation in Cancer Patients Developing Immune-Related Adverse Events
British Journal of Cancer
Cancer Research
Oncology
Management of Anesthesia-Related Adverse Events
THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
EULAR Points to Consider for the Diagnosis and Management of Rheumatic Immune-Related Adverse Events Due to Cancer Immunotherapy With Checkpoint Inhibitors
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Life-Threatening Cardiovascular Adverse Events Related to Pectus Excavatum Surgery
Cardiovascular Disorders and Medicine
Treatment-Related Adverse Events and Response Rate to Immune Checkpoint Inhibition
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Treatment- And Immune-Related Adverse Events of Immune Checkpoint Inhibitors in Advanced Lung Cancer
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
4) Immune-Related Adverse Events in Endocrine Organs Induced by Immune Checkpoint Inhibitors
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
